Frédérique St-Pierre

9PUBLICATIONS
13CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityEarth system sciences
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 21, 2025
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study.

Frederique St-Pierre, Subodh Bhatta, Peter G Doukas

|May 02, 2023
The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma.

Reem Karmali, Frederique St-Pierre, Leo I Gordon

|Jan 18, 2023
Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma.

Frédérique St-Pierre, Leo I Gordon

|Apr 30, 2021
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies.

Frederique St-Pierre, Shailender Bhatia, Sunandana Chandra

|Jan 25, 2021
Severe emesis and acholic stools in a 70-year-old man.

Frédérique St-Pierre, Priya Vijayvargiya, Rosalind F Sharain

|Jan 18, 2021
Bone involvement on PET/CT predicts event-free survival in follicular lymphoma Grade 3B.

Frederique St-Pierre, Stephen M Broski, Betsy R LaPlant

Pageof 2

Frequent Collaborators

2 joint publications

Reem Karmali

1 joint publications

Stephen M Ansell

1 joint publications

Thomas E Witzig

1 joint publications

Matthew Asher Bartlett